Clinical Trial Update: The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 clinical trial sponsored by Sun Yat-sen University evaluating the efficacy of combining transarterial chemoinfusion (TAI) wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN